Literature DB >> 29532986

Laboratory criteria for antiphospholipid syndrome: communication from the SSC of the ISTH.

K M J Devreese1, T L Ortel2, V Pengo3, B de Laat4,5.   

Abstract

Mesh：

Substances：

Year:  2018        PMID： 29532986     DOI： 10.1111/jth.13976

Source DB:  PubMed          Journal:  J Thromb Haemost        ISSN： 1538-7836            Impact factor:   5.824


× No keyword cloud information.
  40 in total

1.  Direct oral anticoagulants versus warfarin in patients with single or double antibody-positive antiphospholipid syndrome.

Authors:  Briana Williams; Joseph J Saseen; Toby Trujillo; Surabhi Palkimas
Journal:  J Thromb Thrombolysis       Date:  2021-11-24       Impact factor: 2.300

2.  The Incidence of Venous Thromboembolism in Critically Ill Patients with SARS-CoV-2 Infection Compared with Critically Ill Influenza and Community-Acquired Pneumonia Patients: A Retrospective Chart Review.

Authors:  Sean Boyd; Kai Sheng Loh; Jessie Lynch; Dhari Alrashed; Saad Muzzammil; Hannah Marsh; Mustafa Masoud; Salman Bin Ihsan; Ignacio Martin-Loeches
Journal:  Med Sci (Basel)       Date:  2022-06-08

Review 3.  Laboratory Diagnosis of Antiphospholipid Syndrome: Insights and Hindrances.

Authors:  Arne Vandevelde; Katrien M J Devreese
Journal:  J Clin Med       Date:  2022-04-13       Impact factor: 4.964

4.  Prevalence and coagulation correlation of anticardiolipin antibodies in patients with COVID-19.

Authors:  Hui Zeng; Meihong Cai; Han Xue; Wen Xie; Xinghua Long
Journal:  Medicine (Baltimore)       Date:  2022-10-14       Impact factor: 1.817

5.  Discovery and characterization of 2 novel subpopulations of aPS/PT antibodies in patients at high risk of thrombosis.

Authors:  Mathivanan Chinnaraj; William Planer; Vittorio Pengo; Nicola Pozzi
Journal:  Blood Adv       Date:  2019-06-11

6.  A Review of Pathophysiology, Clinical Features, and Management Options of COVID-19 Associated Coagulopathy.

Authors:  Julie Goswami; Taleen A MacArthur; Meera Sridharan; Rajiv K Pruthi; Robert D McBane; Thomas E Witzig; Myung S Park
Journal:  Shock       Date:  2021-06-01       Impact factor: 3.533

Review 7.  Antiphospholipid antibodies in critically ill COVID-19 patients with thromboembolism: cause of disease or epiphenomenon?

Authors:  Vittorio Pavoni; Lara Gianesello; Andrew Horton
Journal:  J Thromb Thrombolysis       Date:  2021-05-10       Impact factor: 2.300

8.  Lupus Anticoagulant Single Positivity During the Acute Phase of COVID-19 Is Not Associated With Venous Thromboembolism or In-Hospital Mortality.

Authors:  Nicolas Gendron; Marie-Agnès Dragon-Durey; Richard Chocron; Luc Darnige; Georges Jourdi; Aurélien Philippe; Camille Chenevier-Gobeaux; Jérôme Hadjadj; Jérôme Duchemin; Lina Khider; Nader Yatim; Guillaume Goudot; Daphné Krzisch; Benjamin Debuc; Laetitia Mauge; Françoise Levavasseur; Frédéric Pene; Jeremy Boussier; Elise Sourdeau; Julie Brichet; Nadège Ochat; Claire Goulvestre; Christophe Peronino; Tali-Anne Szwebel; Franck Pages; Pascale Gaussem; Charles-Marc Samama; Cherifa Cheurfa; Benjamin Planquette; Olivier Sanchez; Jean-Luc Diehl; Tristan Mirault; Michaela Fontenay; Benjamin Terrier; David M Smadja
Journal:  Arthritis Rheumatol       Date:  2021-09-22       Impact factor: 15.483

9.  Risk factors of thrombotic recurrence and major bleeding in patients with intermediate-risk for recurrence of venous thromboembolism.

Authors:  Yugo Yamashita; Hidewo Amano; Takeshi Morimoto; Kazushige Kadota; Reo Hata; Kazuki Matsushita; Kohei Osakada; Arata Sano; Toru Takase; Seiichi Hiramori; Kitae Kim; Maki Oi; Masaharu Akao; Yohei Kobayashi; Mamoru Toyofuku; Moriaki Inoko; Tomohisa Tada; Po-Min Chen; Koichiro Murata; Yoshiaki Tsuyuki; Yuji Nishimoto; Tomoki Sasa; Jiro Sakamoto; Minako Kinoshita; Kiyonori Togi; Hiroshi Mabuchi; Kensuke Takabayashi; Takao Kato; Koh Ono; Takeshi Kimura
Journal:  J Thromb Thrombolysis       Date:  2021-07-06       Impact factor: 2.300

Review 10.  Thrombosis risk associated with COVID-19 infection. A scoping review.

Authors:  Fatimah Al-Ani; Samer Chehade; Alejandro Lazo-Langner
Journal:  Thromb Res       Date:  2020-05-27       Impact factor: 3.944
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.